Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

Share Price is delayed by 15 minutes
Get Live Data
2,372.00    -66.00 (-2.71%)
Bid:
2,372.00
Ask:
2,376.00
Spread: 4.00 (0.169%)
Market Cap: £6.16b
WEIR Live PriceLast checked at - London Stock Exchange

Intraday Weir Group Share Chart

Directorate Change

24 Oct 2023 08:39

RNS Number : 1001R
Weir Group PLC
24 October 2023
 

Changes to Board of Directors

The Weir Group PLC ("Weir" or "Weir Group") announces that Penelope (Penny) Freer has been appointed to the Board as an independent Non-Executive Director with effect from 23 October 2023. Penny will succeed Clare Chapman as Chair of the Remuneration Committee with effect from 31 December 2023, when Clare will step down from the Board.

Penny has a background in investment banking, having worked for over 25 years in a range of roles. From 2000 to 2004 Penny led Robert W Baird's UK equities division and prior to this she spent eight years at Credit Lyonnais Securities where she headed the small and mid-cap equities business.

Penny is Chair of The Henderson Smaller Companies Investment Trust plc and Empresaria Group PLC, as well as Chair of AP Ventures LLP. Penny is also currently Chair of Crown Place VCT Plc, and will be stepping down from this role on 22 November 2023 following the company's annual general meeting. Penny has also held a number of non-executive director roles in both public and private companies, including as Senior Independent Director and Chair of the Remuneration Committee at Advanced Medical Solutions Group PLC.

Commenting, Barbara Jeremiah, Chair of the Weir Group said:

"I am delighted to welcome Penny to the Board of Weir. Penny's extensive investment experience, as well as her wide-ranging leadership skills across many businesses, both complement and strengthen our Board as we continue to execute our strategy.

I also wish to thank Clare for her significant contribution to the Weir Group, and the work of the Board, over her six years with us. Her leadership as Remuneration Committee Chair was instrumental in the adoption of The Weir Group Share Reward Plan. On behalf of the Company and the Board, we wish Clare all the best for the future."

Board Committee composition

Following Penny's appointment, the Board Committee membership is now as follows:

Audit Committee

Nomination Committee

Remuneration Committee

Stephen Young (Committee Chair)

Barbara Jeremiah (Board Chair and Committee Chair)

Clare Chapman (Committee Chair)

Srinivasan Venkatakrishnan

Dame Nicola Brewer

Penny Freer (Committee Chair Designate)

Tracey Kerr

Sir Jim McDonald

Dame Nicola Brewer

Ben Magara

Ben Magara

Stephen Young

 

There are no other matters that require disclosure under LR 9.6.13 of the UK Listing Rules.

Enquiries:

Investors: Edward Pears

Media: Sally Jones

Citigate Dewe Rogerson:

Kevin Smith

+44 (0) 141 308 3725

+44 (0) 141 308 3666

+44 (0) 207 638 9571

Weir@citigatedewerogerson.com

 

About The Weir Group PLC

Founded in 1871, The Weir Group PLC is one of the world's leading engineering businesses with a purpose to make its mining and infrastructure customers' operations more sustainable and efficient. Weir's highly engineered technology enables critical resources to be produced using less energy, water and waste while reducing customers' total cost of ownership. The Group is ideally positioned to benefit from structural trends that support long-term demand for its technology including the need for more essential metals to support economic development and carbon transition. The Group has c.12,000 employees operating in over 60 countries with a presence in every major mining region of the world. Find out more at www.global.weir.

 

Weir's ordinary shares trade on the London Stock Exchange (ticker: WEIR LN) and its American Depositary Receipts trade over-the-counter in the USA (ticker: WEGRY).

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOANKQBNOBDKOKB
Date   Source Headline
1st Jun 20262:45 pmRNSDirector/PDMR Shareholding
15th May 20269:16 amRNSHolding(s) in Company
13th May 20268:47 amRNSHolding(s) in Company
11th May 20269:50 amRNSDirector/PDMR Shareholding
8th May 20261:06 pmRNSDirector/PDMR Shareholding
8th May 20268:23 amRNSHolding(s) in Company
30th Apr 20264:24 pmRNSResult of AGM
30th Apr 20267:01 amRNSCEO Succession Announcement
30th Apr 20267:00 amRNSQ1 Trading Update
21st Apr 20262:20 pmRNSDirector/PDMR Shareholding
21st Apr 20262:16 pmRNSDirector/PDMR Shareholding
21st Apr 20262:14 pmRNSDirector/PDMR Shareholding
15th Apr 20264:17 pmRNSDirector/PDMR Shareholding
14th Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20262:48 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSHolding(s) in Company
9th Apr 202610:37 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSDirectorate change
31st Mar 20264:10 pmRNSDirector/PDMR Shareholding
26th Mar 20267:34 amRNSHolding(s) in Company
23rd Mar 202612:06 pmRNS2025 Annual Report and 2026 Annual General Meeting
10th Mar 20269:57 amRNSDirector Declaration
6th Mar 20267:56 amRNSHolding(s) in Company
4th Mar 20262:01 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSWeir completes acquisition of ESEL
2nd Mar 20266:23 pmRNSHolding(s) in Company
16th Feb 20263:53 pmRNSHolding(s) in Company
30th Jan 20262:58 pmRNSHolding(s) in Company
26th Jan 202610:00 amRNS-RWeir receives 'A' score from CDP
14th Jan 20263:26 pmRNS-RWeir and Olayan announce key milestone
15th Dec 20258:36 amRNSDirectorate change
12th Dec 202510:30 amRNSWeir to acquire ESEL
4th Dec 20258:49 amRNSDirector Declaration
3rd Dec 20257:00 amRNSWeir Capital Markets Event
19th Nov 202510:02 amRNSDirector Declaration
11th Nov 20257:00 amRNSWeir completes acquisition of Fast2Mine
5th Nov 202512:20 pmRNSDirector/PDMR Shareholding
5th Nov 20257:00 amRNSQ3 Trading Update
16th Oct 20251:48 pmRNSNotification of Change in Director’s Details
16th Oct 202512:00 pmRNSWeir AUD 400m Bond Pricing
23rd Sep 202512:00 pmRNSWeir to acquire Fast2Mine
22nd Sep 20254:05 pmRNSHolding(s) in Company
22nd Sep 20259:08 amRNSHolding(s) in Company
28th Aug 20255:56 pmRNSDirector/PDMR Shareholding
28th Aug 20255:39 pmRNSWeir completes acquisition of Townley
5th Aug 20253:42 pmRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report
23rd Jul 20257:00 amRNS-RWeir retains CDP A score for climate transparency
30th Jun 202511:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.